Nav: Home

Griffith scientists unlock the 'Malaria box'

August 01, 2016

Griffith University tropical disease researchers have joined together with a host of international laboratories to advance drug discovery for major topical diseases through the creation and testing of the Malaria Box.

In a paper published this week in the top journal PLoS Pathogens, the global team present findings on a panel of 400 chemical compounds -- dubbed the "Malaria Box" -- with potential application as therapeutic starting points for diseases like malaria, trypanosomiasis and toxoplasmosis.

Typically researchers would have been working on their own compounds but this shared collaboration opens new doors for international advances in drug discovery.

The search for new therapies for tropical diseases is of high importance due to a lack of effective vaccines, lack of drugs for some diseases or reduced efficacy of some drugs due to resistance.

Tropical diseases are an enormous health problem, impacting hundreds of millions of lives and killing millions annually. In 2015 the World Health Organisation reported that there were more than 200 million clinical cases of malaria alone, which resulted in an estimated 438,000 deaths. This translates to almost one death due to malaria every minute.

"The work presented in this paper represents a significant step forward in our ability to combat major tropical infectious diseases," says Griffith University researcher Professor Vicky Avery, who was instrumental in selection of the 400 chemical compounds that make up the Malaria Box.

Professor Avery is one of five researcher leaders from the Griffith Eskitis Institute for Drug Discovery who contributed to the global open source drug discovery initiative.

The teams' expertise spans the disciplines of biology and chemistry.

Malaria drug discovery researcher Associate Professor Kathy Andrews, who worked together with chemist Professor Sally-Ann Poulsen and cancer biologist Associate Professor Kathryn Tonissen on the project says: "If we are going to make a difference and help save lives with new drugs we need to think differently."

"The data presented in this paper will be an extremely valuable source of information for drug discovery researchers around the world -- not only those working on tropical diseases but also to those working on other infectious diseases and even cancer." Leading drug discovery researcher and chemist Professor Ron Quinn says the work is a great example of how the Eskitis Institute for Drug Discovery is bridging the gap between chemistry and biology to discover new ways to treat infectious diseases.

"Eskitis researchers are at the cutting edge of drug discovery for infectious diseases and we are delighted to be able to contribute to this important global collaboration," he says.

For more on the paper visit http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005763.
-end-
The Eskitis Institute for Drug Discovery is one of Griffith University's top research centres with a focus on making a difference to human health through the discovery and development of new drugs for infectious diseases, cancers and neurological disorders.

Additional information about work being carried out at the Eskitis Institute for Drug Discovery and on how you can support this research can be found on the following websites:

https://www.griffith.edu.au/science-aviation/eskitis-institute

https://app.secure.griffith.edu.au/donations/info.php

Griffith University

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.